DAFTAR PUSTAKA

Alberti SG, Zimmet P, Shaw J, Grundy SM, 2006, The IDF consensus worlwide
definition of the Metabolic Syndrome, International Diabetes Federation,
Belgium

Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC,
Weiden PJ, 1999, Antipsychotic-Induced Weight Gain: A
Comprehensive Research Synthesis, American Journal of Psychiatry,
156, pp.1686–1696

American Diabetes Association, American Psychiatric Association, American

Association of Clinical Endocrinologists et al., 2004, Consensus
Statement: Consensus Development Conference on Antipsychotic Drugs
and Obesity and Diabetes, Diabetes Care, Vol. 27(2), pp. 596-601

Arango C, Bobes J, Aranda P, Carmena R, Garcia-Garcia M, Rejas J, 2008, A

comparison of schizophrenia outpatients treated with antipsychotics with
and without metabolic syndrome: Findings from CLAMORS study,
Schizophrenia Research 104, pp. 1-12

Badan Penelitian dan Pengembangan Kesehatan, 2007, Riset Kesehatan Dasar,

Pedoman Pengisian Kuesioner, Departemen Kesehatan RI.

Balt SL, Galloway GP, Baggott MJ, Schwartz Z, Mendelson J, 2011, Mechanism
and Genetics of Antipsychotic-Associated Weight Gain, Clinical
Pharmacology and Therapeutics

Basilios B, 2005, Physical Exercise Activity in Individuals with Schizophrenia,

Thesis, The University of Melbourne

Beigh SH, Jain S, 2012, Prevalence of metabolic syndrome and gender

differences, Bioinformation, Vol. 8(13), pp. 613-616

Brown S, Kim M, Mitchell C, Inskip H, 2010, Twenty-five year mortality of a

community cohort with schizophrenia, British Journal of Psychiatry,
196, pp.116-121

Brunero S, Lamont S, Fairbrother G, 2009, Prevalence and Predictors of

Metabolic Syndrome Among Patients Attending an Outpatient Clozapine
Clinic in Australia, Archives of Psychiatric Nursing, Vol. 23, No. 3, pp
261-268

72
 73

Camelia V, 2008, Proporsi Sindrom Metabolik pada Pasien Skizofrenik Rawat

Jalan, Diambil dari : http://repository.usu.ac.id, Diunduh 8 September
2011

Casey DE, 2005, Metabolic issues and cardiovascular disease in patients with
psychiatric disorders, The American Journal of Medicine, Vol. 118, Suppl
2, pp. 15S-22S

Castle DJ, Tran N, Alderton D, 2008, Psychopharmacological management of

schizophrenia, dalam: DJ Castle, DL Copolov, T Wykes, KT Mueser
(eds.), 2008, Pharmacological and Psychosocial Treatments in
Schizophrenia, Second Edition-Revised, pp. 1-22 , Informa UK Ltd,
United Kingdom

Corell CU, Frederickson AM, Kane JM, Manu P, 2007, Does antipsychotic
polypharmacy increase the risk for metabolic syndrome?, Schizophrenia
Research 89, pp. 91-100

Corell CU, Lencz T, Malhotra AK, 2011, Antipsychotic drugs and obesity, Trends
in Molecular Medicine, Vol. 17(2), pp. 97-107

Dahlan MS, 2009, Besar Sampel dan Cara Pengambilan Sampel dalam Penelitian
Kedokteran dan Kesehatan, Penerbit Salemba Medika, Jakarta

Dahlan MS, 2009, Statistik untuk Kedokteran dan Kesehatan, Penerbit Salemba
Medika, Jakarta

Dahlan MS, 2012, Analisis Multivariat Regresi Logistik, Epidemiologi Indonesia,

Jakarta

De Hert MA, Van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A,

Peuskens J, 2006, Prevalence of the metabolic syndrome in patients with
schizophrenia treated with antipsychotic medication, Schizophrenia
Research 83, pp. 87-93

Departemen Kesehatan RI, 1993, Pedoman Penggolongan dan Diagnosis

Gangguan Jiwa di Indonesia III, Jakarta.

Departemen Kesehatan RI, 2006, Keputusan Menteri Kesehatan no

048/MenKes/SK/I/2006 Pedoman Penanggulangan Masalah Kesehatan
Jiwa dan Psikososial pada Masyarakat akibat Bencana dan Konflik.

Fan AZ, Russell M, Naimi T, Li Y, Liao Y, Jiles R, Mokdad AH, 2008, Patterns
of Alcohol Consumption and the Metabolic Syndrome, Journal of
Clinical Endocrinology Metabolism, 93(10), pp. 3833–3838
 74

Feszczur A, 2004, Clozapine Augmentation, Graylands Hospital Drug

Bulletin,Vol.12, No.1

Gardner DM, Murphy AL, O’Donnell H, Centorrino F, Baldessarini RJ, 2010,

International Consensus Study of Antipsychotic Dosing, American
Journal of Psychiatry, 167, pp.686–693

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA,
Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F,
2005, Diagnosis and Management of the Metabolic Syndrome, An
American Heart Association/National Herat, Lung, and Blood Institute
Scientific Statement, Circulation, 112, pp. 2735-2752

Hales RE, Yudofsky SC, Gabbard GO (eds.), 2008, The American Psychiatric
Publishing Textbook of Psychiatry, Fifth Edition, American Psychiatric
Publishing, Inc, Arlington

Hasnain M, Vieweg VR, Fredrickson SK, Beatty-Brooks M, Fernandez A,

Pandurangi AK, 2009, Review: Clinical monitoring and management of
the metabolic syndrome in patients receiving atypical antipsychotic
medications, Primary Care Diabetes 3, pp. 5-15

Haupt DW, 2006, Differential metabolic effects of antipsychotic treatments,

European Neuropsychopharmacology, 16, pp. 149-155

Henderson DC, Miley K, 2009, Glucose Intolerance and Diabetes in Patients With
Schizophrenia, dalam: JM Meyer, HA Nasrallah (eds.), 2009, Medical
Illness and Schizophrenia, Second Edition, pp. 91-115, American
Psychiatric Publishing Inc., Washington DC

IPAQ, 2005, Guidelines for Data Processing and Analysis of the International
Physical Activity Questionnaire (IPAQ), Diambil dari: www.ipaq.ki.se,
Diunduh 1 Maret 2012

Jafar N, 2011, Sindroma Metabolik di Indonesia, Potret Gaya Hidup Masyarakat

Perkotaan, Penerbit Ombak, Yogyakarta

Kapur S, Roy P, Daskalakis J, Remington G, Zipursky R, 2001, Increased

Dopamine D2 Receptor Occupancy and Elevated Prolactin Level
Associated With Addition of Haloperidol to Clozapine, American Journal
of Psychiatry, 158, pp. 311-314

Katzung BG, Masters SB, Trevor AJ (eds.), 2009, Basic and Clinical
Pharmacology, Eleventh Edition, McGraw-Hill Companies, Inc, United
States
 75

Kim J, Tanabe K, Yokoyama N, Zempo H, Kuno S, 2011, Association between

physical activity and metabolic syndrome in middle-aged Japanese: a
cross-sectional study, BMC Public Health, 11:624

Krakowski M, Czobor P, Citrome L , 2008, Weight gain, metabolic parameters,

and the impact of race in aggressive inpatients randomized to double-
blind clozapine, olanzapinee or haloperidol, Schizophrenia Research 110
: 95–102, Elsevier B.V.

Lieberman JA, 2004, Metabolic Changes Associated with Antipsychotic Use,

Primary Care Companion Journal Clinical Psychiatry 6 (suppl 2)

Mackie BD, Zafari AM, 2006, Physical Activity and the Metabolic Syndrome,
Hospital Physician, pp. 26-38

McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer
HY, Hsiao J, Stroup TS, Lieberman JA, 2005, Prevalence of the
metabolic syndrome in patients with schizophrenia: Baseline results from
the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
schizophrenia trial and comparison with national estimates from
NHANES III, Schizophrenia Research 80, pp. 19– 32

Meigs, JB, 2008, The Role of Obesity in Insulin Resistance dalam: BC Hansen,
GA Bray (eds.), 2008, The Metabolic Syndrome Epidemiology, Clinical
Treatment, And Underlying Mechanisms, Humana Press, New Jersey

Mendelson, SD, 2008, Metabolic Syndrome and Psychiatric Illness; Interactions,

Pathophysiology, Assessment and Treatment, Elsevier Inc, USA

MIMS, 2013, Neurology & Psychiatry Indonesia 2013/2014, UBM Medica

MIMS USA, 2012, UBM Medica, diambil dari: http://www.mims.com/USA ,

diunduh 11 Oktober 2012

Misawa F, Shimizu K, Fujii Y, Miyata R, Koshiishi F, Kobayashi M, Shida H,

Oguchi Y, Okumura Y, Ito H, Kayama M, Kashima H, 2011, Is
antipsychotic polypharmacy associated with metabolic syndrome even
after adjustment for lifestyle effect?: a cross sectional study, BMC
Psychiatry, 11, p.118

Moy FM, Bulgiba A, 2010, The modified NCEP ATP III criteria maybe better than
IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala
Lumpur, BMC Public Health, 10, p.678
 76

Nasrallah HA, 2008, Feature Review: Atypical antipsychotic-induced metabolic

side effects: insights from receptor-binding profiles, Molecular
Psychiatry 13, pp. 27–35, Nature Publishing Group

Nasrallah HA, 2009, Medical Outcomes From the CATIE Schizophrenia Study,
dalam: JM Meyer, HA Nasrallah (eds.), 2009, Medical Illness and
Schizophrenia, , Second Edition, pp. 37-60, American Psychiatric
Publishing Inc., Washington DC

Nasrallah HA, Meyer JM, Golf DC, McEvoy JP, Davis SM, Stroup TS,
Lieberman JA, 2006, Low rates of treatment for hypertension,
dyslipidemia, and diabetes in schizophrenia: Data from CATIE
Schizophrenia trial sample at baseline, Schizophrenia Research 86,
pp.15-22

Notoadmodjo S, 2010, Metodologi Penelitian Kesehatan, Rineka Cipta, Jakarta

Paris J, 2010, The Use and Misuse of Psychiatric Drugs, an Evidence-Based

Critique, John Wiley & Sons, Ltd, UK

Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB,

2003, The Metabolic Syndrome: Prevalence and Associated Risk Factor
Findings in the US Population From the Third National Health and
Nutrition Examination Survey, 1988-1994, Archives of Internal
Medicine, 163, pp. 427–436

Patterson J, Albala AA, McCahill ME, Edward TM, 2010, The Therapist’s Guide
to Psychopharmacology; Working with Patiens, Familes, and Physician
to Optimize Care, Revised Ed., The Guilfgord Press, New York

Pedersen, DD, 2010, Pocket Psych Drugs, Point-of-Care Clinical Guide, F.A.
Davis Company, Philadelphia

Peet M, 2004, Diet, diabetes, and schizophrenia: review and hypothesis, British
Journal of Psychiatry, Vol. 184, pp. s102-105

Pranoto A, Kholili U, Tjokroprawiro A , Murtiwi S, Adi S, Wibisono S,

Wirjatmaji B, Purwaningsih, Nurlela I, Wahyuni FD, 2004, Metabolic
Syndrome As Observed in Surabaya, Pusat Diabetes dan Nutrisi, Divisi
Endokrin Metabolik, SMF Penyakit Dalam, RSUD Dr. Soetomo-FK
UNAIR

Rahmad U, 2011, DPR: Indonesia Perlu Memiliki UU Kesehatan Jiwa, Diambil

dari: www.liputan6.com, Diunduh 28 Oktober 2011

Ristiananda DM, 2011, Hubungan antara Status Gizi dan Pola Aktivitas Fisik
 77

dengan Sindrom Metabolik pada Karyawan RSUP Dr. Sardjito

Yogyakarta. Skripsi, Universitas Gadjah Mada

Sadock BJ, Sadock VA, 2010, Kaplan & Sadock’s, Pocket Handbook of Clinical
Psychiatry, Fifth Edition, Lippincott Williams & Wilkins, Philadelphia

Saryono, 2010, Metodologi Penelitian Kesehatan, Penuntun Praktis bagi Pemula,

Mitra Cendikia Press, Yogyakarta

Shin A, Lim S, Sung J, Shin HR, Kim J, 2009, Dietary Inatake, Eating Habits, and
Metabolic Syndrome in Korean Men, Journal American Dietetic
Association, Vol. 109, pp. 633-640

Soewondo P , Purnamasari D, Oemardi M, Waspadji S, Soegondo S, 2010,

Prevalence of Metabolic Syndrome Using NCEP/ATP III Criteria in
Jakarta, Indonesia: The Jakarta Primary Non-Communicable Disease
Risk Factor Surveillance 2006, Acta Medica Indonesiana-Indonesian
Journal Internal Medicine, pp. 199-203

Stahl SM, 2005, Essential Psychopharmacology. The Prescriber’s Guide,

Cambridge University Press, USA

Stahl, SM, 2008, Stahl’s Essential Psychopharmacology, Neuroscientific Basis

and Practical Aplications, Third Edition, Cambridge University Press,
USA

Subardjo, YP, 2009, Pengaruh Aktivitas Fisik terhadap Kejadian Dislipidemia

pada Karyawan RSUP Dr. Sardjito Yogyakarta, Skripsi, Universitas
Gadjah Mada

Sugiyanti E, 2009, Faktor Risiko Obesitas Sentral pada Orang Dewasa di

Sulawesi Utara, Gorontalo, dan DKI Jakarta, Skripsi, Institut Pertanian
Bogor

Taylor D, Mir S, Mace S, Whiskey E, 2002, Co-prescribing of atypical and typical

antipsychotic-prescribing sequence and documented outcome,
Psychiatric Bulletin, 26, 170-172

Tomastola, YA, 2011, Hubungan Asupan Makanan Berisiko dan Aktivitas Fisik
dengan Komponen Sindroma Metabolik pada Tokoh Agama di Manado,
Tesis, Universitas Gadjah Mada

Tyasnugroho, PS, 2008, Hubungan Aktivitas Fisik dengan Resistensi Insulin pada
Remaja Putri Obes, Skripsi, Universitas Gadjah Mada

Van Gaal, LF, 2006, Long-term health considerations in schizophrenia: Metabolic

 78

effects and the role of abdominal adiposity, European

Neuropsychopharmacology, 16, pp. 142-148

Van Kammen DP, Marder SR, 2005, Serotonin-Dopamine Antagonists (Atypical

or Second-Generation Antipsychotics) dalam: BJ Sadock, VA Sadock
(eds.), 2005, Kaplan & Sadock's Comprehensive Textbook of Psychiatry,
Eighth Edition, pp. 2915-2938, Lippincott Williams & Wilkins,
Philadelphia

Wulansih A, Widodo S, 2008, Hubungan antara Tingkat Pengetahuan dan Sikap

Keluarga dengan Kekambuhan pada Pasien Skizofrenia di RSJD
Surakarta, Berita Ilmu Keperawatan, Vol. 1 No. 4 , Desember 2008, pp.
181-186

YunXia Z, MingLiang Z, XuHong H, JunXi L, LiangPu P, Huilin G, Chen W,

WeiPing J, 2011, Cigartte Smoking Increases risk for Incident Metabolic
Syndrome in Chinese Men-Shanghai Diabetes Study, Biomedical and
Environmental Sciences, Vol. 24(5), pp. 475-482

Zagrosek VR, Lehmkul E, Weickert MO, 2006, Gender Differences in the

Metabolic Syndrome and Their Role for Cardiovascular Disease, Clinical
Research in Cardiology, Vol. 95, pp. 136-147